Theravance Biopharma, Inc. Selling, General and Administrative Expense
Theravance Biopharma, Inc. (TBPH) reported Selling, General and Administrative Expense of $14.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-11
- Theravance Biopharma, Inc. selling, general and administrative expense for the quarter ending 2026-06-30 was $14.18M, a 23.08% decline year-over-year.
- Theravance Biopharma, Inc. selling, general and administrative expense for the quarter ending 2026-03-31 was $17.72M, a 3.54% decline year-over-year.
- Theravance Biopharma, Inc. selling, general and administrative expense for the quarter ending 2025-12-31 was $18.52M, a 0.10% increase year-over-year.
- Theravance Biopharma, Inc. selling, general and administrative expense for the quarter ending 2025-09-30 was $18.33M, a 8.64% increase year-over-year.
- Theravance Biopharma, Inc. selling, general and administrative expense for fiscal 2025 was $73.65M, a 6.47% increase from fiscal 2024.
- Theravance Biopharma, Inc. selling, general and administrative expense for fiscal 2024 was $69.17M, a 1.31% decline from fiscal 2023.
- Theravance Biopharma, Inc. selling, general and administrative expense for fiscal 2023 was $70.09M, a 4.51% increase from fiscal 2022.
- Theravance Biopharma, Inc. selling, general and administrative expense for fiscal 2022 was $67.07M, a 32.45% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $14.18M 10-Q · filed 2026-08-11 | $31.90M 10-Q · filed 2026-08-11 | $50.42M derived: sum of 3 quarters · filed 2026-08-11 | $68.75M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | $17.72M 10-Q · filed 2026-05-07 | $36.24M derived: sum of 2 quarters · filed 2026-05-07 | $54.57M derived: sum of 3 quarters · filed 2026-05-07 | $73.00M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | $18.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $36.85M derived: sum of 2 quarters · filed 2026-03-23 | $55.28M derived: sum of 3 quarters · filed 2026-08-11 | $73.65M 10-K · filed 2026-03-23 | ||||
| 2025-09-30 | $18.33M 10-Q · filed 2025-11-12 | $36.76M derived: sum of 2 quarters · filed 2026-08-11 | $55.13M 10-Q · filed 2025-11-12 | $73.63M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | $18.43M 10-Q · filed 2026-08-11 | $36.80M 10-Q · filed 2026-08-11 | $55.30M derived: sum of 3 quarters · filed 2026-08-11 | $72.18M derived: sum of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | $18.37M 10-Q · filed 2026-05-07 | $36.87M derived: sum of 2 quarters · filed 2026-05-07 | $53.75M derived: sum of 3 quarters · filed 2026-05-07 | $70.80M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $18.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $35.38M derived: sum of 2 quarters · filed 2026-03-23 | $52.43M derived: sum of 3 quarters · filed 2026-03-23 | $69.17M 10-K · filed 2026-03-23 | ||||
| 2024-09-30 | $16.88M 10-Q · filed 2025-11-12 | $33.93M derived: sum of 2 quarters · filed 2025-11-12 | $50.67M 10-Q · filed 2025-11-12 | $66.17M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $17.06M 10-Q · filed 2025-08-13 | $33.80M 10-Q · filed 2025-08-13 | $49.29M derived: sum of 3 quarters · filed 2025-08-13 | $65.43M derived: sum of 4 quarters · filed 2025-08-13 | ||||
| 2024-03-31 | $16.74M 10-Q · filed 2025-05-12 | $32.23M derived: sum of 2 quarters · filed 2025-05-12 | $48.38M derived: sum of 3 quarters · filed 2025-05-12 | $67.65M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $15.49M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $31.63M derived: sum of 2 quarters · filed 2025-03-07 | $50.91M derived: sum of 3 quarters · filed 2025-03-07 | $70.09M 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | $16.14M 10-Q · filed 2024-11-14 | $35.42M derived: sum of 2 quarters · filed 2024-11-14 | $54.60M 10-Q · filed 2024-11-14 | $71.33M derived: sum of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | $19.28M 10-Q · filed 2024-08-08 | $38.46M 10-Q · filed 2024-08-08 | $55.19M derived: sum of 3 quarters · filed 2024-08-08 | $71.47M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | $19.18M 10-Q · filed 2024-05-15 | $35.91M derived: sum of 2 quarters · filed 2024-05-15 | $52.19M derived: sum of 3 quarters · filed 2024-05-15 | $68.41M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $16.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $33.01M derived: sum of 2 quarters · filed 2024-03-01 | $49.23M derived: sum of 3 quarters · filed 2024-03-01 | $67.07M 10-K · filed 2024-03-01 | ||||
| 2022-09-30 | $16.28M 10-Q · filed 2023-11-09 | $32.50M derived: sum of 2 quarters · filed 2023-11-09 | $50.34M 10-Q · filed 2023-11-09 | $51.10M 10-Q · filed 2022-11-09 | $71.86M derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | $16.22M 10-Q · filed 2023-08-09 | $16.99M 10-Q · filed 2022-08-08 | $34.06M 10-Q · filed 2023-08-09 | $34.83M 10-Q · filed 2022-08-08 | $55.58M derived: sum of 3 quarters · filed 2023-08-09 | $76.88M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | $17.84M 10-Q · filed 2023-05-10 | $19.12M 10-Q · filed 2022-05-06 | $39.36M derived: sum of 2 quarters · filed 2023-05-10 | $60.66M derived: sum of 3 quarters · filed 2023-05-10 | $86.59M derived: sum of 4 quarters · filed 2023-05-10 | |||
| 2021-12-31 | $21.52M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $42.81M derived: sum of 2 quarters · filed 2023-03-01 | $68.75M derived: sum of 3 quarters · filed 2023-03-01 | $99.30M 10-K · filed 2023-03-01 | ||||
| 2021-09-30 | $21.30M 10-Q · filed 2022-11-09 | $47.23M derived: sum of 2 quarters · filed 2022-11-09 | $77.78M 10-Q · filed 2022-11-09 | $107.70M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $25.93M 10-Q · filed 2022-08-08 | $56.48M 10-Q · filed 2022-08-08 | $86.41M derived: sum of 3 quarters · filed 2023-03-01 | $113.91M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $30.55M 10-Q · filed 2022-05-06 | $60.48M derived: sum of 2 quarters · filed 2023-03-01 | $87.98M derived: sum of 3 quarters · filed 2023-03-01 | $112.76M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $29.93M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $57.43M derived: sum of 2 quarters · filed 2023-03-01 | $82.21M derived: sum of 3 quarters · filed 2023-03-01 | $108.53M 10-K · filed 2023-03-01 | $108.66M 10-K · filed 2021-02-26 | |||
| 2020-09-30 | $27.50M 10-Q · filed 2021-11-08 | $52.28M derived: sum of 2 quarters · filed 2021-11-08 | $78.61M 10-Q · filed 2021-11-08 | $111.65M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-06-30 | $24.78M 10-Q · filed 2021-08-05 | $51.10M 10-Q · filed 2021-08-05 | $84.15M derived: sum of 3 quarters · filed 2022-02-28 | $109.77M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-03-31 | $26.32M 10-Q · filed 2021-05-06 | $59.37M derived: sum of 2 quarters · filed 2022-02-28 | $84.99M derived: sum of 3 quarters · filed 2022-02-28 | $107.22M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $33.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $58.67M derived: sum of 2 quarters · filed 2022-02-28 | $80.89M derived: sum of 3 quarters · filed 2022-02-28 | $106.08M 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $25.62M 10-Q · filed 2020-11-09 | $47.85M derived: sum of 2 quarters · filed 2020-11-09 | $73.03M 10-Q · filed 2020-11-09 | $98.49M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $22.23M 10-Q · filed 2020-08-10 | $47.41M 10-Q · filed 2020-08-10 | $72.87M derived: sum of 3 quarters · filed 2021-02-26 | $94.76M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $25.19M 10-Q · filed 2020-05-08 | $50.64M derived: sum of 2 quarters · filed 2021-02-26 | $72.53M derived: sum of 3 quarters · filed 2021-02-26 | $97.54M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $25.46M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $47.35M derived: sum of 2 quarters · filed 2021-02-26 | $72.35M derived: sum of 3 quarters · filed 2021-02-26 | $97.06M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $21.89M 10-Q · filed 2019-11-08 | $46.90M derived: sum of 2 quarters · filed 2019-11-08 | $71.60M 10-Q · filed 2019-11-08 | $101.12M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-06-30 | $25.01M 10-Q · filed 2019-08-05 | $49.71M 10-Q · filed 2019-08-05 | $79.23M derived: sum of 3 quarters · filed 2020-02-27 | $100.18M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-03-31 | $24.70M 10-Q · filed 2019-05-10 | $54.23M derived: sum of 2 quarters · filed 2020-02-27 | $75.17M derived: sum of 3 quarters · filed 2020-02-27 | $99.51M derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $29.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $50.47M derived: sum of 2 quarters · filed 2020-02-27 | $74.81M derived: sum of 3 quarters · filed 2020-02-27 | $95.59M 10-K · filed 2020-02-27 | ||||
| 2017-09-30 | $20.94M 10-Q · filed 2018-11-08 | $45.28M derived: sum of 2 quarters · filed 2018-11-08 | $66.07M 10-Q · filed 2018-11-08 | $86.44M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-06-30 | $24.34M 10-Q · filed 2018-08-02 | $45.13M 10-Q · filed 2018-08-02 | $65.49M derived: sum of 3 quarters · filed 2019-02-28 | $85.78M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-03-31 | $20.79M 10-Q · filed 2018-05-09 | $41.15M derived: sum of 2 quarters · filed 2019-02-28 | $61.44M derived: sum of 3 quarters · filed 2019-02-28 | $81.70M derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $20.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $40.65M derived: sum of 2 quarters · filed 2019-02-28 | $60.91M derived: sum of 3 quarters · filed 2019-02-28 | $84.51M 10-K · filed 2019-02-28 | ||||
| 2016-09-30 | $20.29M 10-Q · filed 2017-11-08 | $40.55M derived: sum of 2 quarters · filed 2017-11-08 | $64.14M 10-Q · filed 2017-11-08 | $88.21M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-06-30 | $20.26M 10-Q · filed 2017-08-09 | $43.86M 10-Q · filed 2017-08-09 | $67.92M derived: sum of 3 quarters · filed 2018-02-28 | $90.77M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2016-03-31 | $23.60M 10-Q · filed 2017-05-10 | $47.66M derived: sum of 2 quarters · filed 2018-02-28 | $70.50M derived: sum of 3 quarters · filed 2018-02-28 | $92.05M derived: sum of 4 quarters · filed 2018-02-28 | ||||
| 2015-12-31 | $24.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $46.91M derived: sum of 2 quarters · filed 2018-02-28 | $68.45M derived: sum of 3 quarters · filed 2018-02-28 | $90.20M 10-K · filed 2018-02-28 | ||||
| 2015-09-30 | $22.84M 10-Q · filed 2016-11-09 | $44.39M derived: sum of 2 quarters · filed 2016-11-09 | $66.14M 10-Q · filed 2016-11-09 | $87.91M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-06-30 | $21.55M 10-Q · filed 2016-08-09 | $43.29M 10-Q · filed 2016-08-09 | $65.06M derived: sum of 3 quarters · filed 2017-03-01 | $82.77M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $21.75M 10-Q · filed 2016-05-10 | $43.52M derived: sum of 2 quarters · filed 2017-03-01 | $61.23M derived: sum of 3 quarters · filed 2017-03-01 | $74.34M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | $21.77M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $39.48M derived: sum of 2 quarters · filed 2017-03-01 | $52.59M derived: sum of 3 quarters · filed 2017-03-01 | $71.65M 10-K · filed 2017-03-01 | ||||
| 2014-09-30 | $17.70M 10-Q · filed 2015-11-12 | $30.82M derived: sum of 2 quarters · filed 2015-11-12 | $49.88M 10-Q · filed 2015-11-12 | $61.66M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-06-30 | $13.12M 10-Q · filed 2015-08-13 | $32.17M 10-Q · filed 2015-08-13 | $43.95M derived: sum of 3 quarters · filed 2016-03-11 | $52.76M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2014-03-31 | $19.05M 10-Q · filed 2015-05-13 | $30.84M derived: sum of 2 quarters · filed 2016-03-11 | $39.64M derived: sum of 3 quarters · filed 2016-03-11 | $48.20M derived: sum of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | $11.79M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $20.59M derived: sum of 2 quarters · filed 2016-03-11 | $29.14M derived: sum of 3 quarters · filed 2016-03-11 | $35.93M 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | $8.80M 10-Q · filed 2014-11-12 | $17.36M derived: sum of 2 quarters · filed 2014-11-12 | $24.15M 10-Q · filed 2014-11-12 | |||||
| 2013-06-30 | $8.56M 10-Q · filed 2014-08-14 | $15.35M 10-Q · filed 2014-08-14 | ||||||
| 2013-03-31 | $6.79M 10-Q · filed 2014-06-24 | |||||||
| 2012-12-31 | $25.73M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |